Brief by Shorts91 Newsdesk / 06:46am on 01 May 2024,Wednesday Health & Wellness
Former ICMR scientist Dr. Raman Gangakhedkar reassures that only 7 to 8 individuals out of 10 lakh vaccinated with Covishield face the rare side effect of thrombosis thrombocytopenia syndrome (TTS). He highlights that the risk is highest after the first dose but decreases with subsequent doses. Gangakhedkar emphasizes the vaccine's overall positive impact on millions, despite AstraZeneca's acknowledgment of rare blood clotting side effects. With at least 90% of Indians inoculated with Covishield, Gangakhedkar urges understanding of the minimal risk compared to the vaccine's widespread benefits.
